NCT04217850

Brief Summary

Certain blood markers are related to one's ability to successfully lose weight by diet and exercise. Currently, the laboratory tests used to measure these blood markers are expensive and time-consuming. Recently, the Electrical and Computer Engineering Department, at NDSU, invented a device that may be able to measure these blood markers much more quickly and affordably. This study is designed participate, to compare our new device to previous methods. If the new sensor is successful, it will be used as diagnostic tool to personalize weight loss strategies.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 3, 2020

Completed
10 days until next milestone

Study Start

First participant enrolled

January 13, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
Last Updated

May 31, 2022

Status Verified

May 1, 2022

Enrollment Period

4 months

First QC Date

January 2, 2020

Last Update Submit

May 24, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • micro RNA 140

    Venous blood concentrations (M) of micro RNA 140 will be measured using our sensor.

    Change across weeks 0, 6, 13

  • micro RNA 935

    Venous blood concentrations (M) of micro RNA 935 will be measured using our sensor.

    Change across weeks 0, 6, 13

  • Body Composition

    Change in body composition (% fat) derived from dual x-ray absorptiometry

    Change across weeks 0, 6, 13

  • Lean body mass

    Change in lean body mass (kg) derived from dual x-ray absorptiometry

    Change across weeks 0, 6, 13

  • Fat mass

    Change in fat mass (kg) derived from dual x-ray absorptiometry

    Change across weeks 0, 6, 13

  • Body mass

    Change in body mass (kg) derived from scale

    Change across weeks 0, 6, 13

Secondary Outcomes (5)

  • High-density lipoprotein

    Change across weeks 0, 6, 13

  • Total cholesterol

    Change across weeks 0, 6, 13

  • Triglycerides

    Change across weeks 0, 6, 13

  • Low-density lipoprotein (calculated)

    Change across weeks 0, 6, 13

  • Very low-density lipoprotein (calculated)

    Change across weeks 0, 6, 13

Study Arms (1)

500 kcal Energy Deficit

EXPERIMENTAL

The goal of the nutrition and exercise intervention will be to induce an energy deficit of approximately 500 kcals/day over the 12-week period in order to induce an approximate 5% weight loss in all participants.

Other: 250 kcal Dietary Energy RestrictionOther: Aerobic Exercise

Interventions

The nutrition intervention will be individualized and implemented as a free-living energy-restricted eating plan where energy intake will be based on a mild restriction (approx. 250 kcal/day).

500 kcal Energy Deficit

Supervised aerobic exercise will be combined with the energy restriction. Individuals will perform aerobic exercise (treadmill, cycle, or rower or combination) 4-5 days per week for 12 weeks. At each session they will expend 250 or more calories to further meet or exceed the 500 kcal energy deficit.

500 kcal Energy Deficit

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • generally healthy
  • body mass index 25-34.9
  • able to do physical activity and exercise

You may not qualify if:

  • currently participating in a structured diet or excise program,
  • pregnant,
  • currently use any nicotine product
  • diagnosed neuromuscular disease
  • diabetes,
  • uncontrolled high blood pressure,
  • diagnosed cancer,
  • previously had a heart attack or other chronic heart related conditions that are not controlled with medicine
  • difficulty moving without assistive devices or walking one-quarter mile
  • are taking medications that influence muscle size (testosterone, growth hormone, etc.),
  • have had bariatric surgery
  • have a body mass greater than 350lbs,
  • fear blood, blood draws, or needles
  • adverse reaction to a blood draw in the past.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

North Dakota State University

Fargo, North Dakota, 58102, United States

Location

MeSH Terms

Conditions

OverweightObesityWeight Loss

Interventions

Exercise

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2020

First Posted

January 3, 2020

Study Start

January 13, 2020

Primary Completion

May 4, 2020

Study Completion

June 30, 2020

Last Updated

May 31, 2022

Record last verified: 2022-05

Locations